Sinopharm
1099.HK
1,98 €
Share price
-0.46%
Change (1 day)
-23.12%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Revenue for Sinopharm (1099.HK)
Revenue in 2023 (TTM): €59.51 Billion
According to Sinopharm's latest financial reports the company's current revenue (TTM 
) is €74.23 Billion. an increase over the revenue in the year 2022 that were of €70.41 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sinopharm from 2006 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | €74.23 B | 5.42% |
| 2022 | €70.41 B | -2.1% |
| 2021 | €71.92 B | 16.85% |
| 2020 | €61.55 B | 14.95% |
| 2019 | €53.54 B | 21.52% |
| 2018 | €44.06 B | 5.93% |
| 2017 | €41.59 B | 27.22% |
| 2016 | €32.69 B | 5.37% |
| 2015 | €31.02 B | 9.14% |
| 2014 | €28.42 B | 17.22% |
| 2013 | €24.25 B | 25.94% |
| 2012 | €19.25 B | 34.61% |
| 2011 | €14.30 B | 55.34% |
| 2010 | €9.20 B | 35.79% |
| 2009 | €6.78 B | 37.56% |
| 2008 | €4.93 B | 31.43% |
| 2007 | €3.75 B | 40.26% |
| 2006 | €2.67 B |